Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, Circular RNAs in diseases, MicroRNA in disease regulation, and RNA modifications and cancer.
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
TMEM64 aggravates the malignant phenotype of glioma by activating the Wnt/β-catenin signaling pathway
Integrative analysis of genomic and epigenomic regulation reveals miRNA mediated tumor heterogeneity and immune evasion in lower grade glioma
UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma
Additional file 1 of m6A-mediated upregulation of LINC01003 regulates cell migration by targeting the CAV1/FAK signaling pathway in glioma
Additional file 2 of m6A-mediated upregulation of LINC01003 regulates cell migration by targeting the CAV1/FAK signaling pathway in glioma
Additional file 5 of m6A-mediated upregulation of LINC01003 regulates cell migration by targeting the CAV1/FAK signaling pathway in glioma
Long non-coding RNA TTTY15 sponges miR-520a-3p to exacerbate neural apoptosis induced by cerebral ischemia/reperfusion via targeting IRF9 both in vivo and in vitro
PDPK1 regulates autophagosome biogenesis by binding to PIK3C3
Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor
PDPK1 regulates autophagosome biogenesis by binding to PIK3C3
A nuclear lncRNA Linc00839 as a Myc target to promote breast cancer chemoresistance via PI3K/AKT signaling pathway
Evaluation of the inhibitory effect of tacrolimus combined with mycophenolate mofetil on mesangial cell proliferation based on the cell cycle
Increased NHE1 expression is targeted by specific inhibitor cariporide to sensitize resistant breast cancer cells to doxorubicin in vitro and in vivo
Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma
Neuronal necrosis is regulated by a conserved chromatin-modifying cascade